CSACI Statement on Allergies and the COVID 19 mRNA vaccine

Read the Canadian Society of Allergy and Clinical Immunology (CSACI) position statement on those with allergies and the COVID mRNA vaccine here. CSACI clearly states “those with other allergic problems are no more likely to experience an allergic reaction to the COVID-19 vaccine than the general population and should safely be able to receive this vaccine—this includes those with a history of serious allergic reactions or anaphylaxis to substances that are not an ingredient in this vaccine, and those with food allergy, eczema, allergic rhinitis (hayfever), asthma, or stinging insect allergy.”